Drug intelligence / Profile preview

miR-139-3p mimic

Development stage
Preclinical
Lead developer
Kagoshima University
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

miR-139-3p mimic is a synthetic, double-stranded RNA oligonucleotide designed to replicate the biological activity of the endogenous microRNA miR-139-3p. In the context of bladder cancer, miR-139-3p is identified as a tumor suppressor that is frequently downregulated. The mimic acts by restoring the levels of this microRNA, which then directly targets the Matrix Metallopeptidase 11 (MMP11) gene. By binding to the MMP11 mRNA, the mimic inhibits its expression, which in turn suppresses the migration and invasion of cancer cells. This therapeutic approach is being explored for its potential to treat advanced and muscle-invasive bladder cancer.

Other names
microRNA-139-3p mimicmicroRNA139-3p mimicmicroRNA 139-3p mimichsa-miR-139-3p mimichsa-miR139-3p mimichsa-miR 139-3p mimic
02

Targets

MMP11 (Matrix metalloproteinase-11 (MMP11) mRNA)TRIP13 (Thyroid hormone receptor interactor 13)KIF18B

Beyond the preview

Go deeper on miR-139-3p mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-139-3p mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call